NF1 and connective tissue neoplasm: This prospective study of malignancy risk in 448 patients with NF1 has shown substantially increased relative risks for CNS and connective tissue tumours over the general population, contributing to an estimated overall risk of malignancy of 36% (95% CI=27–46%) by age 70 years.